Yoshie Imai and Tomoka Sakamoto : ヘルスプロモーション, Nankodo, Tokyo, May 2024.
Academic Paper (Judged Full Paper):
1.
Yoshie Imai, MIYAMOTO Yoko, YOSHIDA Yukiko, Yuta Inoue, IMAI Hironori, YAMADA Kazuyo, Tomoka Sakamoto and Hiroyuki Morino : ASCERTAINING THE VIEWS OF HEREDITARY CANCER SYNDROME PATIENTS RECEIVING GENETIC COUNSELING AND THEIR FAMILIES REGARDING GENETIC TESTING, Journal of Comprehensive Nursing Research and Care, 10, 2, 219, 2025.
(Summary)
This study investigates how genetic information could be shared by ascertaining the views of patients receiving genetic counseling (GC) for suspected hereditary cancer and their families regarding genetic testing. We conducted a questionnaire survey of hereditary cancer syndrome patients receiving GC for the first time after the disclosure of genetic testing results as well as their spouses and at-risk relatives. A total of 81 people responded: 50 patients who received GC during the study period, 18 spouses, and 13 at-risk relatives. We found significant differences in responses to the questions ``1-1: Are you interested in genetic testing?'' (p < .003), ``1-5: Do you think genetic testing has drawbacks?'' (p < .007), ``1-9: Is it necessary to undergo genetic testing?'' (p < .001), and ``Q2: How did you think about communicating genetic information to family or relatives?'' (p < .003) between patients and spouses. There was a significant difference among all groups for ``1-4: Do you want to clarify whether you have a genetic variant or not?'' (p < .001). We also found a significant difference in the question ``1-11: Is genetic testing too expensive?'' between patients on one side and spouses and at-risk relatives on the other (p < .001). We surveyed the views on genetic testing of hereditary cancer syndrome patients and their families and found that both groups recognize the importance of learning the test results. However, the two groups did not agree on ``Do you want to clarify whether you have a genetic variant or not?'' through genetic testing.
(Keyword)
genetic counseling / hereditary cancer syndrome patients / genetic testing